Liver Cancer Manager vs OPOM Usage & Stats
NOTE: This app now integrates with the Health app so if you choose to also manage certain heart conditions and have an Apple Watch or other device that creates heart rate data, you can now send that data to your doctor through the app giving you full control over which data you send. No health data is collected or sent from device without you specifically doing it.
Getting the Full Picture of Your Liver Cancer (Hepatocellular Cancer)
When you are living with Liver Cancer, the Liver Cancer Manager can help you manage the symptoms that affect you every day. Studies show that people with chronic diseases can positively affect their lives by using @Point of Care apps to track pain, medications, and more—giving a sense of control over their conditions.
For many, the best part of using Liver Cancer Manager, is seeing moods, pain, medications—even how often they journal—in colorful pie charts. When your health journey is presented this way, it is easier to spot trends, notice strengths, and identify areas of concern.
When You Download Liver Cancer Manager and Register, You Can:
• Track your progress and symptoms by filling in the daily journal with its sliders and buttons and watch your data transform into easy-to-read charts
• Manage your medications and treatments, including reminders
• Use the photo upload feature to share visible symptoms with care providers
• Connect to care providers so they can monitor your progress between visits and better understand how your condition is affecting you
• Stay up-to-date with the latest information on Liver Cancer when you access the “Learn More” section
• In-app Help guides you through the features so you can get the most out of the app
• Experience the new animated feature @Points Rewards and accumulate badges by using the app
A Wealth of Medical Expertise Going Back to 1980
Our @Point of Care platform is an award-winning digital technology. It provides mobile, desktop, digital clinical answers at the point of care through Projects In Knowledge™. To be able to connect with you and share your HIPAA-protected information, tell your care provider to download our @Point of Care Suite App or register online at www.atpointofcare.com.
- Apple App Store
- Free
- Medical
Store Rank
- -
The successful clinical application of liver transplantation has generated a discrepancy between supply and demand, thereby generating a persistent insufficient organ supply that results in thousands of candidate deaths every year while candidates await liver transplantation.
Given the scarcity of this resource, the Model for End-Stage Liver Disease (MELD) accurately prioritizes a waitlisted candidate’s likelihood of death within the near future, so that the limited supply of donated livers can be allocated to maximize the benefit from transplantation. The MELD score was updated in 2014 and 2015.
The objective of OPOM is to improve the accuracy of the MELD method and include hepatocellular carcinoma (HCC) patients, and then demonstrate effectiveness with simulation.
The first order requirement to implement an allocation methodology is to achieve alignment on methodology. This methodology aims to determine the probability that a patient will either die or become unsuitable for liver transplantation within three months, given his or her individual characteristics, and then allocate the limited supply of donated livers to the patients that need it and then maximize benefit of transplantation
Interpretability and transparency of the underlying processes is required to achieve alignment.
Based on the work by D. Bertsimas, J. Kung, N. Trichakis, Y. Wang, R. Hirose and P. Vagefi https://doi.org/10.1111/ajt.15172
- Apple App Store
- Free
- Medical
Store Rank
- -
Liver Cancer Manager vs. OPOM ranking comparison
Compare Liver Cancer Manager ranking trend in the past 28 days vs. OPOM
Rank
No Data Available
Liver Cancer Manager vs. OPOM ranking by country comparison
Compare Liver Cancer Manager ranking trend in the past 28 days vs. OPOM
No Data to Display
Compare to any site with our free trial
Liver Cancer Manager VS.
OPOM
January 3, 2025